Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection

NCT04553068 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1892

Enrollment

INDUSTRY

Sponsor class

Conditions

Sexually Transmitted Diseases
Gonorrhea
Chlamydia

Interventions

DRUG: EVO100
DRUG: Placebo

Sponsor

Evofem Inc.